Intravenous glutamine enhances COX-2 activity giving cardioprotection.
Neilan, Tom G
Redmond, J Mark
AffiliationThe Royal College of Surgeons in Ireland, Department of Surgery, Beaumont Hospital, Dublin, Ireland.
MeSH6-Ketoprostaglandin F1 alpha
HSP72 Heat-Shock Proteins
Ischemic Preconditioning, Myocardial
Myocardial Reperfusion Injury
MetadataShow full item record
CitationIntravenous glutamine enhances COX-2 activity giving cardioprotection. 2009, 152 (1):140-7 J. Surg. Res.
JournalThe Journal of surgical research
AbstractPreconditioning, a highly evolutionary conserved endogenous protective response, provides the most powerful form of anti-infarct protection known. We investigated whether acute intravenous glutamine, through an effect on cyclooxygenase (COX)-2 and heat shock protein (HSP) 72, might induce preconditioning.
Male New Zealand white rabbits (n = 28) received either 0.5 g/kg glutamine in 0.9% saline or saline only in divided doses for 3 d. The large marginal branch of the left coronary was occluded for 30 min; cardiac function was assessed during 3 h of reperfusion, and infarct size was measured. 6-Keto-PGF-1alpha, nitrate, and malonaldehyde serum levels were determined. Hearts were taken from a further group of pretreated rabbits (n = 10) to assess myocardial COX-2 and HSP72 levels.
Glutamine pretreatment resulted in a 39% reduction in infarct size (30.7 +/- 2.0% versus 50.4 +/- 2.1% controls; P < 0.01). Myocardial COX-2 levels were significantly elevated with pretreatment (P < 0.05) and were mirrored by higher serum 6-keto-PGF-1alpha levels prior to ischemia (69 +/- 13 versus 18 +/- 21 pg/mL in controls, P = 0.027). There was no significant difference in myocardial HSP72 or serum nitrate levels following pretreatment, or malonaldehyde levels during reperfusion.
Glutamine pretreatment confers anti-infarct protection through up-regulation of COX-2, a key mediator of delayed preconditioning protection. Previous confirmation of its clinical safety profile at these doses suggests an acceptable strategy for inducing preconditioning for perioperative protection.
- Myocardial protection using an omega-3 fatty acid infusion: quantification and mechanism of action.
- Authors: McGuinness J, Neilan TG, Sharkasi A, Bouchier-Hayes D, Redmond JM
- Issue date: 2006 Jul
- Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
- Authors: Jiang X, Shi E, Nakajima Y, Sato S, Ohno K, Yue H
- Issue date: 2005 May 17
- Preconditioning effects of steroids and hyperoxia on cardiac ischemia-reperfusion injury and vascular reactivity.
- Authors: Kaljusto ML, Stensløkken KO, Mori T, Panchenko A, Frantzen ML, Valen G, Vaage J
- Issue date: 2008 Mar
- [Protective effect of heat-shock protein 27 on myocardium with isoflurane preconditioning in myocardial ischemia/reperfusion injury of myocardium in rabbit].
- Authors: Ran K, Zhu R, Lu XH, Zou DQ, Li H, Chang YT
- Issue date: 2007 Nov
- Cardiac remodelling hinders activation of cyclooxygenase-2, diminishing protection by delayed pharmacological preconditioning: role of HIF1 alpha and CREB.
- Authors: Feng J, Lucchinetti E, Fischer G, Zhu M, Zaugg K, Schaub MC, Zaugg M
- Issue date: 2008 Apr 1